TABLE 1.
Clinical, angiographic, and procedural characteristics
| Clinical characteristics (n = 56 patients) | |
|---|---|
| Age, years | 62 ± 10 |
| Male | 47 (84%) |
| Body mass index | 27 ± 3 |
| Diabetes mellitus type II | 4 (7%) |
| Hypertension | 25 (45%) |
| Hyperlipidaemia | 28 (50%) |
| Current tobacco use | 5 (9%) |
| Family history of CAD | 28 (50%) |
| Prior myocardial infarction | 7 (13%) |
| Prior PCI | 7 (13%) |
| Invasive coronary angiography (n = 63 vessels) | |
| Treated vessel | |
| LAD | 39 (62%) |
| LCX | 8 (13%) |
| RCA | 16 (25%) |
| Before PCI a | |
| Reference diameter, mm | 2.77 ± 0.46 |
| MLD, mm | 0.86 ± 0.39 |
| Diameter stenosis, % | 69 ± 13 |
| Lesion length | 17.1 [11.9–31.0] |
| After PCI a | |
| Reference diameter, mm | 2.83 ± 0.42 |
| MLD, mm | 2.49 ± 0.46 |
| Diameter stenosis, % | 12 ± 9 |
| Procedural characteristics (n = 63 vessels) | |
| Stent length, mm | 28 [18–38] |
| Nominal stent diameter, mm | 3.32 ± 0.35 |
| Final stent diameter after implantation, mm | 3.74 ± 0.44 |
a
Quantitative coronary analysis.
Abbreviations: CAD, coronary artery disease; MLD, minimal luminal diameter; PCI, percutaneous coronary intervention.